ArticleCell reports. Medicine2023

Preclinical characterization of the Toll-like receptor 7/8 antagonist MHV370 for lupus therapy.

Stuart Hawtin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.